Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

INTRODUCTION: Given the challenges concerning the differential diagnosis of dementia, we investigated the possible added value of monoaminergic compounds to the standard cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Particularly, regarding the AD versus dementia with Lewy bodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssens, Jana, Vermeiren, Yannick, Fransen, Erik, Aerts, Tony, Van Dam, Debby, Engelborghs, Sebastiaan, De Deyn, Peter P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Blood-Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852321/
https://www.ncbi.nlm.nih.gov/pubmed/29552632
http://dx.doi.org/10.1016/j.dadm.2018.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852321/
https://www.ncbi.nlm.nih.gov/pubmed/29552632
http://dx.doi.org/10.1016/j.dadm.2018.01.002

Ejemplares similares